The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

He's warning others of the potential dangers - despite shedding three-and-a-half stone. Georgie Aldous, from Great Yarmouth ...

Recent studies show medications like Ozempic, originally designed for type 2 diabetes and weight loss, may help people ...

A man who ‘thought he was going to die’ after using the ‘King Kong’ of weight loss injections is warning others of the ...

Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy said: “Christmas is upon us and for individuals ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...